Point72 Asset Management is back as a disclosed short seller in pharmaceutical company Camurus, according to the Swedish Financial Supervisory Authority’s register.
There are three disclosed short sellers in the company. In total, 4.75 percent of the capital is shorted.
The Swedish Financial Supervisory Authority requires positions above 0.1 percent to be reported and short positions above 0.5 percent to be disclosed.
Point72 was most recently a disclosed short seller in Camurus until mid-July.
